HCPLive Network

Atherosclerosis Noted in Pediatric HIV Patients

 
THURSDAY, Dec. 6 (HealthDay News) -- Children and adolescents with HIV have a significantly increased intima-media thickness (IMT), according to a study presented at the European Society of Cardiology's EUROECHO & other Imaging Modalities 2012, held from Dec. 5 to 8 in Athens, Greece.

Talia Sainz Costa, M.D., from the University General Hospital Gregorio Maranon in Madrid, Spain, and colleagues used echocardiography to evaluate carotid IMT in 150 HIV-infected pediatric and adolescent patients and 150 controls. Anthropometric and lipid measures were recorded.

The researchers found that IMT was significantly thicker in HIV patients compared with control subjects (0.434 versus 0.424; P = 0.018). HIV was independently associated with thicker IMT (odds ratio, 2.68) after adjustment for age, sex, body mass index, and smoking status. In subgroup analysis of 34 patients with HIV and 11 controls for whom immune activation markers were determined, frequencies of activated T CD4+ cells were significantly higher among HIV infected patients. Compared to patients with undetectable viral loads or control subjects, treated and viremic patients had the highest frequency of CD4+ and CD8+ activation and senescence.

"HIV research is investigating ways to control the inflammation and immune activation with agents such as probiotics, aspirin, and corticoids. In the meantime clinicians need to focus on ensuring their young patients with HIV take the antiretroviral treatment, take lipid lowering drugs when necessary, and adopt healthier lifestyles," Sainz Costa said in a statement.
 

Press Release
More Information

 
Copyright © 2012 HealthDay. All rights reserved.
 
 

Further Reading
Implantable cardioverter-defibrillators (ICDs) have prevented cardiac arrests and deaths, but they carry a risk of giving patients shocks when they don’t need them. That inappropriate shock rate has been estimated as occurring in 10 to 20% of patients with the devices, causing unnecessary hospital admissions, and a negative impact on patients’ quality of life. They are also associated with increased morbidity and mortality for some patients. But in a study in Heart Rhythm Angelo Auricchio, MD, PhD, and colleagues report on technological improvements in a Medtronic device that has reduced those shocks to 1.5% with a dual/triple chamber defibrillator and 2.5% for a single chamber ICD after one year.
Automated external defibrillators installed and ready for use in many public spaces can save lives when needed, but the U.S. Food and Drug Administration says that since 2005, it has also received 72,000 reports of the devices failing.
A novel oral anticoagulant’s trial performance has led European regulators to approve its use in cardioversion for patients with atrial fibrillation.
More Reading